NCT00478881 - A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function | Biotech Hunter

Enrollment

397

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions

Overactive BladderDetrusor Overactivity

Interventions

DRUG

Vardenafil HCl (Levitra, BAY38-9456)

vardenafil hydrochloride 10 mg film-coated tablets twice daily (BID) for oral (by mouth) intake for 6 weeks

DRUG

Placebo

vardenafil hydrochloride-matching film-coated tablets BID for oral intake for 6 weeks

Trial Locations (55)

1082

Budapest

1126

Budapest

1200

Bruxelles - Brussel

4031

Basel

10115

Berlin

13347

Berlin

15706

Santiago de Compostela

16303

Schwedt

17475

Greifswald

18014

Granada

28046

Madrid

31096

Haifa

40235

Düsseldorf

41063

Mönchengladbach

42103

Wuppertal

45147

Essen

46010

Valencia

66538

Neunkirchen

75571

Paris

75970

Paris

79312

Emmendingen

91031

Jerusalem

92637

Weiden

94086

Bad Griesbach-Therme

105425

Moscow

125206

Moscow

198013

Saint Petersburg

V8V 3N1

Victoria

N3R 4N3

Brantford

N2N 2B9

Kitchener

H3T 1E2

Montreal

775 20

Olomouc

140 59

Prague

160 00

Prague

04103

Leipzig

Unknown

Petah Tikva

5623 EJ

Eindhoven

1081 HV

Amsterdam

1105 AZ

Amsterdam

6229 HX

Maastricht

3015 CE

Rotterdam

3584 CX

Utrecht

85-168

Bydgoszcz

41-500

Chorzów

08-110

Siedlce

01-432

Warsaw

02-005

Warsaw

02-777

Warsaw

2720-276

Amadora

1069-166

Lisbon

4050-013

Porto

4099-001

Porto

3046-853

S. Martinho Do Bispo

08035

Barcelona

08036

Barcelona